These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31102571)

  • 21. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
    Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
    Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance.
    Mamawala MK; Meyer AR; Landis PK; Macura KJ; Epstein JI; Partin AW; Carter BH; Gorin MA
    BJU Int; 2020 Jun; 125(6):861-866. PubMed ID: 32039537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S; Gertner M; Maganti M; Pintilie M; Perlis N; Toi A; Evans AJ; Finelli A; van der Kwast TH; Ghai S
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores.
    Okubo Y; Sato S; Hasegawa C; Koizumi M; Suzuki T; Yamamoto Y; Yoshioka E; Ono K; Washimi K; Yokose T; Kishida T; Miyagi Y
    Hum Pathol; 2023 May; 135():99-107. PubMed ID: 36738975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.
    Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Roobol MJ; Helleman J; van Leenders GJLH
    Histopathology; 2020 Apr; 76(5):755-762. PubMed ID: 31944367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools.
    Downes MR; Liu KN; Yu Y; Lajkosz K; Kroon LJ; Hollemans E; Fleshner N; Finelli A; van Leenders GJLH; Iczkowski KA; van der Kwast TH
    Clin Genitourin Cancer; 2024 Feb; 22(1):47-55. PubMed ID: 37558528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
    Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
    BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
    Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
    J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
    Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B
    Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications.
    Yaxley WJ; Nouhaud FX; Raveenthiran S; Franklin A; Donato P; Coughlin G; Kua B; Gianduzzo T; Wong D; Parkinson R; Brown N; Samaratunga H; Delahunt B; Egevad L; Roberts M; Yaxley JW
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):398-405. PubMed ID: 32999464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI?
    Aslim EJ; Law YXT; Fook-Chong SMC; Ho HSS; Yuen JSP; Lau WKO; Lee LS; Cheng CWS; Ngo NT; Law YM; Tay KJ
    BJU Int; 2021 Aug; 128(2):178-186. PubMed ID: 33539650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?
    Jansen BHE; Nieuwenhuijzen JA; Oprea-Lager DE; Yska MJ; Lont AP; van Moorselaar RJA; Vis AN
    Urol Oncol; 2019 Mar; 37(3):181.e1-181.e6. PubMed ID: 30558983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological parameters and stromal desmoplastic status affecting accurate diagnosis of extraprostatic extension of prostate cancer using multi-parametric magnetic resonance imaging.
    Okano K; Miyai K; Mikoshi A; Edo H; Ito K; Tsuda H; Shinmoto H
    Int J Urol; 2024 May; 31(5):475-482. PubMed ID: 38193247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
    Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
    Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.
    Seyrek N; Hollemans E; Osanto S; Pelger RCM; van der Poel HG; Bekers E; Bangma CH; Rietbergen J; Roobol MJ; Schoots IG; van Leenders GJLH
    Histopathology; 2022 Feb; 80(3):558-565. PubMed ID: 34706119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of the Highest-Grade Lesion in Multifocal Discordant Prostate Cancer by Multiparametric Magnetic Resonance Imaging.
    Matsumoto K; Akita H; Hashiguchi A; Takeda T; Kosaka T; Fukumoto K; Yasumizu Y; Tanaka N; Morita S; Mizuno R; Asanuma H; Oya M; Jinzaki M
    Clin Genitourin Cancer; 2024 Jun; 22(3):102084. PubMed ID: 38608334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
    Luzzago S; Colombo A; Mistretta FA; Alessi S; Di Trapani E; Summers PE; Piccinelli ML; Raimondi S; Vignati S; Clemente A; Rosati E; di Meglio L; d'Ascoli E; Scarabelli A; Zugni F; Belmonte M; Maggioni R; Ferro M; Fusco N; de Cobelli O; Musi G; Petralia G
    Radiology; 2023 Nov; 309(2):e223349. PubMed ID: 37987657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
    Giannarini G; Cereser L; Como G; Bonato F; Pizzolitto S; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
    Acta Radiol; 2021 Jul; 62(7):949-958. PubMed ID: 32718179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
    Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
    Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.